# Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus

> **NCT00361153** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 35 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Colesevelam hydrochloride
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00361153
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-10
- **Final completion:** 2007-03
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2008-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00361153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00361153, "Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00361153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*